Clinical trials: Aplastic Anaemia
Sever Aplastic Anaemia
A Bioequivalence Study of Hetrombopag in Healthy Subjects
This study consists of two parts. Part 1 is a pilot BE study, and Part 2 is a pivotal study to demonstrate the bioequivalence of test and reference formulation, both of which adopt a single-center, randomized, open-label…
- Trial name
- NCT05088655
- Testing
- Hetrombopag Olamine Tablet
- Where
- China
- Volunteers
- 58 people
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
Sever Aplastic Anaemia
A Trial of Hetrombopag in Healthy and Hepatic Impairment Subjects
This is a single-dose, open-label, phase I clinical study evaluating the PK of hetrombopag in subjects with mild hepatic impairment (Child-Pugh Class A), subjects with moderate hepatic impairment (Child-Pugh Class B), as well as…
- Trial name
- NCT05088642
- Testing
- Hetrombopag Olamine Tablet
- Where
- China
- Volunteers
- 24 people
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
Sever Aplastic Anaemia
A Trial of Hetrombopag in Healthy Subjects
This is a single-center, single-arm, open-label, self-controlled, phase I clinical study. A total of 26 male or female healthy subjects are intended to be enrolled to evaluate the PK drug-drug interaction between ciclosporin and…
- Trial name
- NCT05088174
- Testing
- Hetrombopag Olamine Tablet；Ciclosporin Soft Capsule
- Where
- China
- Volunteers
- 26 people
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.